Home › Funds › Squadron Capital Management LLC › EWTX
Squadron Capital Management LLC position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
Squadron Capital Management LLC reported holding 425,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$17.3M, representing 6.84% of its reported portfolio and ranking #2 among its reported holdings. Squadron Capital Management LLC has disclosed EWTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Squadron Capital Management LLC's EWTX position evolved
Squadron Capital Management LLC first disclosed a stake in EWTX in Q4 2025 at 350,000 shares (US$8.7M). The position peaked in Q3 2026 at 425,000 shares, worth US$17.3M. Across 4 filings, Squadron Capital Management LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 425,000 shares valued at US$17.3M — an increase of 135,000 shares quarter over quarter.. Notable position changes include a 47% increase in Q3 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 350.00K | $8.69M | New |
| Q1 2026 | 350.00K | $11.03M | Hold |
| Q2 2026 | 290.00K | $11.78M | Reduce |
| Q3 2026 | 425.00K | $17.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.1M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$340.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.05M · Q3 2026
- Paradigm Biocapital Advisors LP 10.78M sh · $437.61M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $340.74M · Q3 2026
- Novo Holdings A/S 5.35M sh · $217.21M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.40M sh · $178.72M · Q3 2026
- PERCEPTIVE ADVISORS LLC 4.14M sh · $168.01M · Q3 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.29M · Q3 2026
- Siren, L.L.C. 2.80M sh · $113.85M · Q3 2026
- First Light Asset Management, LLC 2.48M sh · $100.81M · Q3 2026
- BRAIDWELL LP 2.07M sh · $84.01M · Q3 2026
- Cormorant Asset Management, LP 1.86M sh · $75.52M · Q3 2026
- MPM BioImpact LLC 1.58M sh · $63.99M · Q3 2026
More on Squadron Capital Management LLC
FAQ
How long has Squadron Capital Management LLC held EWTX?
Squadron Capital Management LLC has disclosed EWTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Squadron Capital Management LLC's current position in EWTX?
As of Q3 2026, Squadron Capital Management LLC holds 425.00K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $17.25M, representing 6.84% of its reported portfolio and ranking #2.
Has Squadron Capital Management LLC been buying or selling EWTX?
In the latest 13F filing (Q3 2026), Squadron Capital Management LLC increased its position in EWTX. The position peaked in Q3 2026 at 425.00K shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.